Government approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 12 and 15
The government approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 12 and 15, becoming the first vaccine to be approved used for children in Japan.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthGovernment approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 12 and 15
View Premium plansBrowse free archive reportsThe government approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 12 and 15, becoming the first vaccine to be approved used for children in Japan.